{"id":456167,"date":"2021-03-11T11:43:05","date_gmt":"2021-03-11T16:43:05","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=456167"},"modified":"2021-03-11T11:43:05","modified_gmt":"2021-03-11T16:43:05","slug":"valbiotis-2021-financial-communication-calendar","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/valbiotis-2021-financial-communication-calendar\/","title":{"rendered":"VALBIOTIS: 2021 Financial Communication Calendar"},"content":{"rendered":"<p>        <!--.bwalignc { text-align: center; list-style-position: inside }\n.bwuline { text-decoration: underline }body {font:normal small Arial,Helvetica,sans-serif;color:#000;background-color:#fff;padding:24px;margin:0;} a img {border:0;} h3 {font-size:medium;color:#000;margin:0 0 1em 0; text-align:center;}-->  <\/p>\n<p class=\"bwalignc\"><b>VALBIOTIS: 2021 Financial Communication Calendar<\/b><\/p>\n<p>LA ROCHELLE, France&#8211;(<a href=\"http:\/\/www.businesswire.com\">BUSINESS WIRE<\/a>)&#8211;<br \/>\nRegulatory News:\n<\/p>\n<p>\nVALBIOTIS (Paris:ALVAL) (FR0013254851 \u2013 ALVAL \/ eligible for the PEA\/SME), a Research &amp; Development company committed to scientific innovation for preventing and combating metabolic diseases, today presents its 2021 financial communication calendar.\n<\/p>\n<p>\n&#8211; March, 17: Annual Report (after market closing)\n<\/p>\n<p>\n&#8211; May, 27: General Meeting (terms of participation to be specified later)\n<\/p>\n<p>\n&#8211; September, 30: Half-year Report (after market closing)\n<\/p>\n<p><b>ABOUT VALBIOTIS<br \/>\n<br \/><\/b>VALBIOTIS is a Research &amp; Development company committed to scientific innovation for preventing and combating metabolic diseases in response to unmet medical needs.<br \/>\n<br \/>VALBIOTIS has adopted an innovative approach, aiming to revolutionize healthcare by developing a new class of nutritional health solutions designed to reduce the risk of major metabolic diseases, based on a multi-target approach and made possible by the use of plant-based ingredients.<br \/>\n<br \/>Its products are intended to be licensed to players in the health world.<br \/>\n<br \/>VALBIOTIS was founded in La Rochelle in early 2014 and has formed numerous partnerships with top academic centers. The Company has established three sites in France \u2013 P\u00e9rigny, La Rochelle (17) and Riom (63).<br \/>\n<br \/>VALBIOTIS is a member of the \u201cBPI Excellence\u201d network and received \u201cInnovative Company\u201c status awarded by BPI France. Valbiotis has also been awarded \u201cYoung Innovative Company\u201d status and has received major financial support from the European Union for its research programs via the European Regional Development Fund (ERDF). VALBIOTIS is a PEA-SME eligible company.\n<\/p>\n<p>\nFind out more about VALBIOTIS: <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.valbiotis.com&amp;esheet=52394457&amp;newsitemid=20210311005429&amp;lan=en-US&amp;anchor=www.valbiotis.com&amp;index=1&amp;md5=8b362dbdf7b9a15814b0c37574115c87\">www.valbiotis.com<\/a><\/p>\n<p class=\"bwalignc\">\nName: VALBIOTIS<br \/>\n<br \/>ISIN code: FR0013254851<br \/>\n<br \/>Mnemonic code: ALVAL<br \/>\n<br \/>EnterNext\u00a9 PEA-SME 150\n<\/p>\n<p><b>DISCLAIMER<br \/>\n<br \/><\/b>This press release contains forward-looking statements about VALBIOTIS&#8217; objectives. VALBIOTIS considers that these projections are based on rational hypotheses and the information available to the company at the present time. However, in no way does this constitute a guarantee of future performance, and these projections may be reconsidered based on changes in economic conditions and financial markets, as well as a certain number of risks and uncertainties, including those described in the VALBIOTIS registration document, filed with the French Financial Markets Regulator (AMF) on 31 July 2020 (application number R 20-018). This document is available on the Company&#8217;s website (<span class=\"bwuline\"><a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.valbiotis.com&amp;esheet=52394457&amp;newsitemid=20210311005429&amp;lan=en-US&amp;anchor=www.valbiotis.com&amp;index=2&amp;md5=7f6414ba3bcfc973ec1bb0a1045e042d\">www.valbiotis.com<\/a><\/span>).\n<\/p>\n<p>\nThis press release, as well as the information contained herein, does not constitute an offer to sell or subscribe to, or a solicitation to purchase or subscribe to, VALBIOTIS&#8217; shares or securities in any country.\n<\/p>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210311005429r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" style=\"width:0;height:0\" \/><span class=\"bwct31415\" \/><\/p>\n<p id=\"mmgallerylink\"><span id=\"mmgallerylink-phrase\">View source version on businesswire.com: <\/span><span id=\"mmgallerylink-link\"><a href=\"https:\/\/www.businesswire.com\/news\/home\/20210311005429\/en\/\" rel=\"nofollow\">https:\/\/www.businesswire.com\/news\/home\/20210311005429\/en\/<\/a><\/span><\/p>\n<p>\nVALBIOTIS \/ CORPORATE COMMUNICATION<br \/>\n<br \/>Carole Rocher \/ Marc Delaunay<br \/>\n<br \/>+33 5 46 28 62 58<br \/>\n<br \/><a rel=\"nofollow\" href=\"mailto:media@valbiotis.com\">media@valbiotis.com<\/a><\/p>\n<p>\nACTIFIN \/ FINANCIAL COMMUNICATION<br \/>\n<br \/>St\u00e9phane Ruiz<br \/>\n<br \/>+33 1 56 88 11 14<br \/>\n<br \/><a rel=\"nofollow\" href=\"mailto:sruiz@actifin.fr\">sruiz@actifin.fr<\/a><\/p>\n<p><b>KEYWORDS:<\/b> Europe United States North America France<\/p>\n<p><b>INDUSTRY KEYWORDS:<\/b> Health Fitness &amp; Nutrition Clinical Trials Research Science Pharmaceutical Biotechnology<\/p>\n<p><b>MEDIA:<\/b><\/p>\n<table cellpadding=\"3\" cellspacing=\"3\">\n<tr>\n<td><font face=\"Arial\" size=\"2\"><b>Logo<\/b><\/font><\/td>\n<\/tr>\n<tr>\n<td><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20210311005429\/en\/682222\/3\/logo_valbiotis.jpg\" alt=\"Logo\" \/><\/td>\n<\/tr>\n<tr>\n<td><font face=\"Arial\" size=\"2\"><\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"<p>VALBIOTIS: 2021 Financial Communication Calendar LA ROCHELLE, France&#8211;(BUSINESS WIRE)&#8211; Regulatory News: VALBIOTIS (Paris:ALVAL) (FR0013254851 \u2013 ALVAL \/ eligible for the PEA\/SME), a Research &amp; Development company committed to scientific innovation for preventing and combating metabolic diseases, today presents its 2021 financial communication calendar. &#8211; March, 17: Annual Report (after market closing) &#8211; May, 27: General Meeting (terms of participation to be specified later) &#8211; September, 30: Half-year Report (after market closing) ABOUT VALBIOTIS VALBIOTIS is a Research &amp; Development company committed to scientific innovation for preventing and combating metabolic diseases in response to unmet medical needs. VALBIOTIS has adopted an innovative approach, aiming to revolutionize healthcare by developing a new class of nutritional health solutions designed to reduce the risk &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/valbiotis-2021-financial-communication-calendar\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;VALBIOTIS: 2021 Financial Communication Calendar&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-456167","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>VALBIOTIS: 2021 Financial Communication Calendar - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/valbiotis-2021-financial-communication-calendar\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"VALBIOTIS: 2021 Financial Communication Calendar - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"VALBIOTIS: 2021 Financial Communication Calendar LA ROCHELLE, France&#8211;(BUSINESS WIRE)&#8211; Regulatory News: VALBIOTIS (Paris:ALVAL) (FR0013254851 \u2013 ALVAL \/ eligible for the PEA\/SME), a Research &amp; Development company committed to scientific innovation for preventing and combating metabolic diseases, today presents its 2021 financial communication calendar. &#8211; March, 17: Annual Report (after market closing) &#8211; May, 27: General Meeting (terms of participation to be specified later) &#8211; September, 30: Half-year Report (after market closing) ABOUT VALBIOTIS VALBIOTIS is a Research &amp; Development company committed to scientific innovation for preventing and combating metabolic diseases in response to unmet medical needs. VALBIOTIS has adopted an innovative approach, aiming to revolutionize healthcare by developing a new class of nutritional health solutions designed to reduce the risk &hellip; Continue reading &quot;VALBIOTIS: 2021 Financial Communication Calendar&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/valbiotis-2021-financial-communication-calendar\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-03-11T16:43:05+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210311005429r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/valbiotis-2021-financial-communication-calendar\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/valbiotis-2021-financial-communication-calendar\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"VALBIOTIS: 2021 Financial Communication Calendar\",\"datePublished\":\"2021-03-11T16:43:05+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/valbiotis-2021-financial-communication-calendar\\\/\"},\"wordCount\":444,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/valbiotis-2021-financial-communication-calendar\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20210311005429r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/valbiotis-2021-financial-communication-calendar\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/valbiotis-2021-financial-communication-calendar\\\/\",\"name\":\"VALBIOTIS: 2021 Financial Communication Calendar - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/valbiotis-2021-financial-communication-calendar\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/valbiotis-2021-financial-communication-calendar\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20210311005429r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"datePublished\":\"2021-03-11T16:43:05+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/valbiotis-2021-financial-communication-calendar\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/valbiotis-2021-financial-communication-calendar\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/valbiotis-2021-financial-communication-calendar\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20210311005429r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20210311005429r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/valbiotis-2021-financial-communication-calendar\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"VALBIOTIS: 2021 Financial Communication Calendar\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"VALBIOTIS: 2021 Financial Communication Calendar - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/valbiotis-2021-financial-communication-calendar\/","og_locale":"en_US","og_type":"article","og_title":"VALBIOTIS: 2021 Financial Communication Calendar - Market Newsdesk","og_description":"VALBIOTIS: 2021 Financial Communication Calendar LA ROCHELLE, France&#8211;(BUSINESS WIRE)&#8211; Regulatory News: VALBIOTIS (Paris:ALVAL) (FR0013254851 \u2013 ALVAL \/ eligible for the PEA\/SME), a Research &amp; Development company committed to scientific innovation for preventing and combating metabolic diseases, today presents its 2021 financial communication calendar. &#8211; March, 17: Annual Report (after market closing) &#8211; May, 27: General Meeting (terms of participation to be specified later) &#8211; September, 30: Half-year Report (after market closing) ABOUT VALBIOTIS VALBIOTIS is a Research &amp; Development company committed to scientific innovation for preventing and combating metabolic diseases in response to unmet medical needs. VALBIOTIS has adopted an innovative approach, aiming to revolutionize healthcare by developing a new class of nutritional health solutions designed to reduce the risk &hellip; Continue reading \"VALBIOTIS: 2021 Financial Communication Calendar\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/valbiotis-2021-financial-communication-calendar\/","og_site_name":"Market Newsdesk","article_published_time":"2021-03-11T16:43:05+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210311005429r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/valbiotis-2021-financial-communication-calendar\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/valbiotis-2021-financial-communication-calendar\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"VALBIOTIS: 2021 Financial Communication Calendar","datePublished":"2021-03-11T16:43:05+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/valbiotis-2021-financial-communication-calendar\/"},"wordCount":444,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/valbiotis-2021-financial-communication-calendar\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210311005429r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/valbiotis-2021-financial-communication-calendar\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/valbiotis-2021-financial-communication-calendar\/","name":"VALBIOTIS: 2021 Financial Communication Calendar - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/valbiotis-2021-financial-communication-calendar\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/valbiotis-2021-financial-communication-calendar\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210311005429r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","datePublished":"2021-03-11T16:43:05+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/valbiotis-2021-financial-communication-calendar\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/valbiotis-2021-financial-communication-calendar\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/valbiotis-2021-financial-communication-calendar\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210311005429r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210311005429r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/valbiotis-2021-financial-communication-calendar\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"VALBIOTIS: 2021 Financial Communication Calendar"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/456167","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=456167"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/456167\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=456167"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=456167"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=456167"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}